Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) association with RBP-J is essential for regulation of virus and cell gene transcription and B lymphocyte transformation into infinitely proliferating lymphoblastoid cells (LCLs). To identify EBNA2-regulated cell genes in LCLs, an EBV recombinant that expresses EBNA2 with its C terminus fused in frame to a 4-hydroxytamoxifen (4HT)-dependent mutant estrogen receptor (E2HTF) was used to transform primary B lymphocytes to LCLs. In the presence of 4HT, E2HTF expression level and effects on the LMP1 promoter in transfected BJAB lymphoblasts were similar to EBNA2. In 4HT-supplemented medium, E2HTF EBV recombinant infected LCLs were also similar to EBNA2 LCLs in outgrowth but required higher serum and a restricted range of cell concentrations for consistent growth. In medium without 4HT, E2HTF localized to the cytoplasm, c-myc levels substantially decreased within 6 h, cells stopped growing, and levels of other EBNAs and LMP1 remained stable for 24 h. Over this 24-h period, 30 cell RNAs decreased 2-fold, and 51 other RNAs decreased 1.5-fold. These RNAs encode proteins important in cell adhesion or signaling, transcription, RNA processing, cell-cycle regulation, and survival. Real-time RT-PCR confirmed EBNA2-dependent expression of eight RNAs.
Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) association with RBP-J is essential for regulation of virus and cell gene transcription and B lymphocyte transformation into infinitely proliferating lymphoblastoid cells (LCLs). To identify EBNA2-regulated cell genes in LCLs, an EBV recombinant that expresses EBNA2 with its C terminus fused in frame to a 4-hydroxytamoxifen (4HT)-dependent mutant estrogen receptor (E2HTF) was used to transform primary B lymphocytes to LCLs. In the presence of 4HT, E2HTF expression level and effects on the LMP1 promoter in transfected BJAB lymphoblasts were similar to EBNA2. In 4HT-supplemented medium, E2HTF EBV recombinant infected LCLs were also similar to EBNA2 LCLs in outgrowth but required higher serum and a restricted range of cell concentrations for consistent growth. In medium without 4HT, E2HTF localized to the cytoplasm, c-myc levels substantially decreased within 6 h, cells stopped growing, and levels of other EBNAs and LMP1 remained stable for 24 h. Over this 24-h period, 30 cell RNAs decreased 2-fold, and 51 other RNAs decreased 1.5-fold. These RNAs encode proteins important in cell adhesion or signaling, transcription, RNA processing, cell-cycle regulation, and survival. Real-time RT-PCR confirmed EBNA2-dependent expression of eight RNAs.
RBP-J͞CBF1 ͉ c-myc

I
n primary human infection, Epstein-Barr virus (EBV) establishes a latency III (LTIII) infection in B lymphocytes, which is characterized by expression of EBV-encoded nuclear antigens (EBNAs), integral membrane proteins (LMP1 and LMP2), small RNAs (EBERs), and Bam A rightward transcripts. LTIII-infected cell lymphoproliferation is limited by T cell immune responses to EBNAs and LMPs (1, 2) . EBNA2 and EBNALP are the first EBV proteins expressed in B lymphocyte infection (1) . EBNALP and EBNA2 enhance their upstream promoters, Cp or Wp, which results in transcription of not only EBNALP and EBNA2 but also EBNA3A, EBNA3B, EBNA3C, and EBNA1 (for review see ref. 1 ). EBNA2 and EBNALP also turn on the EBV LMP1, LMP2B, and LMP2A promoters. EBNA2 directly or indirectly up-regulates B lymphocyte CD21, CD23, c-myc, AML2, BATF, IL16, IL18r, c-fgr, cyclin D2, cdk4, TNF-␣, lymphotoxin, HES1, and G-CSF RNAs (1, (3) (4) (5) (6) (7) .
EBNA2 stably associates with the sequence-specific DNA binding protein RBP-J͞CBF1 (1) , which has at least one cognate site within 500 bp upstream of the Cp, LMP1, LMP2A, and CD23 promoters and within the first intron of the CD21 promoter. EBNALP coactivates with EBNA2 by interaction with the EBNA2 acidic transcriptional activation domain, association with HA95 and PKA, and displacement of HP1␣ from PML bodies (1, (8) (9) (10) . The EBNA2 acidic transcriptional activation domain recruits basal and activation-related transcription factors, TAF40, TFIIB, TFIIH, p300͞CBP, PCAF histone acetyltransferases, and a p100 transcription coactivator to promoters (1, 11) . The EBNA2 RBP-J association and acidic activating domains are essential for B lymphocyte conversion to lymphoblastoid cells (LCLs) (1) . Furthermore, EBNA3A polypeptides and EBNA2 peptides, which specifically disrupt EBNA2 association with RBP-J, reduce CD21, CD23, and c-myc expression and halt LCL growth (12, 13) .
The experiments reported here investigate EBNA2 effects on B lymphocyte RNA levels and cell growth by using LCLs transformed by a reverse genetically engineered EBV recombinant that is conditional for EBNA2 activity. The conditional EBNA2 mutation (E2HT) was made by fusing the N terminus of the 4-hydroxytamoxifen (4HT)-dependent mutant estrogen receptor (ER) hormone binding domain (14) to the EBNA2 ORF C terminus. Oligonucleotide arrays were used to comprehensively assess cell RNA differences among LCLs infected with WT EBV, EBV E2HT in media with 4HT, and EBV E2HT in media without 4HT.
Results
E2HTF Is a Conditional EBNA2
. E2HT stability and function were compared with WT EBNA2 after addition of a C-terminal Flag epitope (E2HTF and E2F, respectively) and with WT EBNA2. Expression of E2HTF in non-EBV-infected BJAB B lymphoblasts resulted in detection of a single 120-kDa E2HTF protein in media with or without 4HT, which was similar in abundance to 78-kDa WT EBNA2 and 80-kDa E2F proteins (Fig. 1) . Furthermore, EBNA2, E2F, and E2HTF, in medium with 4HT, activated EBV LMP1 ( Fig. 1 ) and Cp (data not shown) promoters 6-fold, whereas, in the absence of 4HT, E2HTF had little or no effect on these promoters. Thus, under permissive conditions E2HTF is similar to EBNA2 in LMP1 and Cp promoter activation, whereas under nonpermissive conditions E2HTF is ineffective in LMP1 promoter activation.
EBV Recombinants That Conditionally Express EBNA2.
To further evaluate the role of EBNA2-mediated transcription in LCL growth, cord blood lymphocytes were transformed with WT or E2HTF recombinant virus. W91 EcoRI A DNA with either WT EBNA2 or E2HTF was used to restore the missing DNA segment from the EBNALP-and EBNA2-deleted P3HR1 EBV genome. WT EBNA2-and E2HTF-infected cord blood lymphocytes plated in media with 4HT yielded similar numbers of LCLs at 6-8 weeks.
E2HTF-Infected LCL Growth and LTIII Protein Expression in the Presence and Absence of 4HT. E2HTF LCLs remained completely 4HT-dependent for continued growth but differed from WT LCLs in their growth. In 4HT-containing media, E2HTF LCLs required 15% FBS, whereas WT LCLs grew similarly in 10% or 15% FBS. Also, continued expansion of E2HTF LCLs in 4HT media required maintenance at 1-3 ϫ 10 5 cells per ml, whereas WT LCLs could be maintained at 1-8 ϫ 10 5 per ml. After E2HTF LCLs reached 3 ϫ 10 5 per ml, the number of apoptotic cells increased, whereas the number of viable cell remained constant. Even at 1-3 ϫ 10 5 cells per ml, E2HTF cells were prone to spontaneous cessation of proliferation and gradual death. Nevertheless, at 1-3 ϫ 10 5 cells per ml, E2HTF-infected cells usually grew at the same rate as WT LCLs ( Fig. 2A) .
E2HTF-infected LCLs did not increase in viable cell number over 48 h after shift to complete medium without 4HT (Fig. 2 A,  4HTϪ) . Growth ceased at multiple points in cell cycle. In 4HT-containing media, E2HTF-infected LCLs were 61% in G 0 ͞G 1 , 21% in S, 9% in G 2 ͞M, and 9% SubG 1 , whereas, in media without 4HT, LCLs were 70% in G 0 ͞G 1 , 14% in S, 7% in G 2 ͞M, and 9% SubG 1 (Fig. 2B) . Thus, EBNA2 inactivation results in decreased cell-cycle entry and progression without increased apoptosis.
E2HTF fusion protein localized to LCL nuclei in medium with 4HT and relocalized to LCL cytoplasm within 4-6 h after cell transfer to medium without 4HT (data not shown). All E2HTF staining was gone by 24 h (Fig. 2C) . Cell E2HTF levels decreased 50% over each 8-h period after switching to medium without 4HT (Fig. 2D) . E2HTF was almost completely absent by 24 h in medium without 4HT (Fig. 2D) .
Although expression of other EBNAs and LMP1 is EBNA2-dependent, EBNALP, EBNA1, EBNA3A, and LMP1 protein levels did not decrease Ͼ2-fold over 48 h in media without 4HT (Fig. 2E) . Concordant with sustained LMP1 protein levels, gel-shift activity with an NF-B probe did not change over these 48 h (data not shown). Lack of change in EBNA1 and EBNA3A protein levels is due to protein stability, whereas lack of change in EBNALP and LMP1 protein levels may be due to relatively high mRNA levels in LCLs (1, 15, 16) .
E2HTF Inactivation Results in Decreased c-myc and CD23 Expression.
As expected, c-myc expression was highly E2HTF-and 4HT-dependent in LCLs (Fig. 3A) (5, 12, 17) . Myc protein decreased within 6 h after transfer of E2HTF LCLs to media without 4HT (Fig. 3A) , consistent with the short half-life of c-myc protein and message and the key role for EBNA2 in c-myc transcription in LCLs. The CD23 mRNA level fell to 50% of initial levels at 16 h in medium without 4HT (Fig. 3B ).
Expression Profiling of EBNA2-Induced Cellular Genes. Human oligonucleotide arrays (Affymetrix HU-133A) were used to assess changes in mRNA levels in E2HTF LCLs 24h after 4HT withdrawal (five arrays) in comparison with the same cells grown in media with 4HT (seven arrays), with newly derived WT EBNA2 LCLs (five arrays), and with an established LCL (IB4; four arrays). Of 22,000 array elements, 6,196 were detected in the nine WT LCL arrays and were analyzed for potential changes in E2HTF LCLs growing in media with 4HT versus without 4HT. When RNAs from WT LCLs and E2HTF LCLs in media with 4HT were compared with RNAs from E2HTF LCLs in media without 4HT, RNAs homologous to 78 array elements were Ͼ2-fold E2HTF-dependent; 33 were significant by Welch t test with P Ͻ 0.05 and are shown in Fig. 4A . Of these 33, 6 were 2-fold EBNA2-dependent using the most stringent Bonferroni multiple testing correction with P Ͻ 0.05 (Fig. 4 , **) and 13 others by the Benjamini-Hochberg test with P Ͻ 0.05 (Fig. 4, *) . These 33 array elements detect 30 distinct cell RNAs including c-myc, CD21, CD23, and 27 novel EBNA2-induced RNAs. The CD23 change by array hybridization correlated well with Northern blot analysis (Figs. 3B and 4A ).
An additional 55 array elements detected 51 other distinct cell RNAs that were 1.5-fold EBNA2-dependent, 18 with P Ͻ 0.05 by Bonferroni and 37 others with P Ͻ 0.01 by Benjamini-Hochberg (Fig. 4B) . The difference in level of expression of the RNAs induced 2-fold by EBNA2 as opposed to RNAs induced 1.5-fold is apparent in comparison of Fig. 4 A and B .
Comparison of the expression levels of the 81 EBNA2-induced RNAs in WT LCLs, E2HTF LCLs in media with 4HT, and E2HTF LCLs in media without 4HT reveals a more consistent difference in levels between WT LCLs and E2HTF LCLs in media without 4HT than is apparent when E2HTF LCLs in media with 4HT are compared with E2HTF LCLs in media without 4HT (Fig. 4) . These data are consistent with the hypothesis that E2HTF in media with 4HT is, in some experiments, equivalent to WT EBNA2 and, in others, hypofunctional and more similar to E2HTF in media without 4HT.
Overall, 47 RNAs were expressed at levels in E2HTF LCLs in media with 4HT that were intermediate between levels in WT and E2HTF LCL in media without 4HT, whereas 27 RNAs were at similar levels in WT and E2HTF LCLs in media with 4HT (Fig. 4) . Higher levels of these 27 RNAs are more likely to be required for LCL growth or survival. These 27 RNAs encode MTA1, AKAP1, C20orf59, STAT6, KIAA0233, ZNF593, ICB-1, TUBGCP2, CCL5, NIFIE14, MRPL12, CD23A, HPMT1L2, TRIO, CDK5R1, MGC10993, CBX6, NUP62, PEF, EIF3S9, APRT, CRIP2, MAD1L1, MYC, DIPA, PABPC4, and JUND. In contrast, the remaining seven RNAs, which encode ICAM2, ATF5, PFTK1, EVL, SHMT2, PIK4CA, and Hs.194637, were expressed at high levels in WT LCLs but at similar low levels in E2HTF LCLs in media with or without 4HT. These RNAs are less likely to be critical for LCL growth.
Interestingly, no RNAs were consistently up-regulated in the 24 h after E2HTF LCLs were placed in media without 4HT. Thus, EBNA2 down-regulated RNAs were not identified through this analysis.
Previous experiments of this type used LCLs transformed by dual infection with the EBNA2-deleted P3HR-1 EBV and an EBV defective consisting of concatemers of EBNALP-and 
EBNA2-encoding
expression and low LMP1 expression in medium containing estrogen, as well as estrogen effects on cell RNA levels (3). To investigate whether 4HT could have residual effects on endogenous hormone receptors, RNAs that were up-regulated by 4HT in E2HTF LCLs were compared with RNAs that were up-regulated by 4HT in EBNA3AHT LCLs (15) 
Validation of EBNA2-Induced Genes by Quantitative Real-Time RT-PCR.
RT-RCR was used to validate array data for eight EBNA2-induced genes ( Table 1 , which is published as supporting information on the PNAS web site). The eight genes varied from 1.06 to 3.03 in an array-based ratio of E2HTF LCL RNA levels in media with 4HT to media without 4HT. By RT-PCR, MTA1 RNA levels averaged 1.5-fold higher in media with 4HT than in media without 4HT, whereas ATF5, ATP1B1, CCL5, CDK5R1, CRIP1, RGS1, and JUND averaged Ͼ2.5-fold higher in E2HTF LCLs in media with 4HT versus media without 4HT. Except for MTA1, RT-PCRdetermined EBNA2-induced changes in RNA levels were greater than array-determined changes.
Computer Analysis of EBNA2-Responsive Elements Associated with
Promoters for EBNA2-Induced RNAs. DNA near promoters for the EBNA2-induced RNAs identified in these experiments was analyzed for EBNA2-responsive elements associated with the LMP1, LMP2A, and Cp promoters, including RBP-J (GTGGGAA, CTGGGAA, or GTGAGAA), Pu.1 (RRGGGAAYY), and CBF2 (CAGTGCGT). Overall, 64% of 67 EBNA2-induced genes had at least one site in the 1,500 bp upstream of the transcriptional start site; slightly Ͼ56% were found in the promoters of 124 randomly chosen genes. A more stringent search for combination of RBP-J and Pu.1 or CBF2 sites within 2,500 bp upstream of the promoters did not improve specificity. Because the first intron of CD21 and c-myc include an RBP-J site, a search based on a first-intron RBP-J site was undertaken but had little specificity. A search based on two RBP-J sites within the 500-bp upstream region had better specificity in identifying 6 of 67 EBNA2-induced genes versus only 2 of 124 control genes but failed to identify the majority of EBNA2-regulated genes. Thus, promoter responsiveness to EBNA2 may require additional combinatorial components beyond those currently identified. Indeed, even in the LMP1 promoter, other transcription factors are critical for EBNA2 responsiveness (18) . Also, some of the EBNA2-regulated RNAs may be secondarily affected by other EBNA2 up-regulated transcription factors. only IRF4 and Hey1 were up-regulated Ͼ1.5-fold in E2HTF LCLs in media with 4HT versus media without 4HT with P Ͻ 0.05. However, IRF4 and Hey1 expression levels in WT LCLs were negligible, and these RNAs were excluded from our analyses. Although EBNA2 and NotchIC are similar in activating gene expression through RBP-J͞CBF1, in recruitment of p300͞CBP (11, 22) , and in potential activation of some EBV and cell promoters (23), EBNA2 up-regulates genes in B lymphoblasts that are different from those that Notch IC up-regulates in thymocytes. Furthermore, NotchIC only partially and transiently rescued EBNA2 inactivation in the ER͞EBNA2 system, suggesting a limited functional overlap between these proteins (17) .
Intersection Between EBNA2-Induced Genes and Genes
Discussion
These experiments identify EBNA2-regulated cell genes in LCLs through a comparison of RNA levels in LCLs transformed by an EBV recombinant that conditionally expresses E2HTF and WT LCLs. The conditional E2HTF mutation approximates WT EBNA2 transcriptional activation in media with 4HT and was functionally inactivated in LCLs within 6 h of incubation in media without 4HT. E2HTF docked in the cytoplasm, and c-myc protein substantially decreased within 6 h. Importantly, EBNA1, EBNALP, EBNA3C, and LMP1 protein levels were largely unaffected by E2HTF inactivation in the first 24 h, enabling detection of the role of E2HTF in regulating 6,196 detected cell RNAs. Consequently, 78 new EBNA2 up-regulated cell RNAs were identified ( Table 2 , which is published as supporting information on the PNAS web site). These RNAs are not affected by a similar EBNA3A HT fusion protein (ref. 24 and data not shown), consistent with no 4HT effect on endogenous ERs or through the HT component of the E2HTF fusion protein.
EBNA2 up-regulated RNAs are likely to be important for LCL growth and survival. Certainly, EBNA2-mediated c-myc upregulation has a central role in EBV-mediated LCL growth. Many of c-myc's effects on cell growth are through transcription of cell RNAs necessary for cell-cycle entry and progression. Indeed, switch of E2HTF cells to media without 4HT resulted in accumulation of cells in G 0 ͞G 1 . Transcriptional profiling of an LCL that had been converted to a BL phenotype by overexpression of a tetracycline conditional c-myc identified Ͼ300 c-myc-induced RNAs (25), of which only 5 (ZRF1, AKAP1, SLC7A5, HRMT1L2, and IRAK1) were among the 78 RNAs that were at least 1.5-fold EBNA2-induced. Thus, 73 of the previously unidentified EBNA2-induced RNAs are not likely downstream of c-myc.
Some of these 73 EBNA2 up-regulated genes likely collaborate with c-myc in maintaining LCL growth and survival, because c-myc expression in LCLs in the absence of EBNA2 regulation of other cell RNAs results in apoptosis or conversion to a BL phenotype (12, 26) .
EBNA2-induced RNAs encode several transcription factors aside from c-myc that are likely important for B cell proliferation, including STAT6, RBBP6, TZFP, MAFF, MTA1, and ATRX. STAT6 is important for B cell growth and survival (27) . In inducing STAT6, EBNA2 mimics the IL-4 pathway and partially replaces the T cell-derived IL-4 proliferation signal that is important for normal B cell proliferation. RBBP6 is a zinc finger transcription factor that binds to hypophosphorylated pRb and is repressed in terminal differentiation (28) . TZFP (FAZF) is also a zinc finger transcription factor which is highly expressed in proliferating hematopoietic progenitor cells and interacts with the Fanconi anemia complementation group C protein (29) . Defective TZFP is associated with pancytopenea and predisposition to cancer. MAFF is a bZIP transcription factor in the v-maf avian musculo-aponeuronal fibrosarcoma oncogene family, which binds to and regulates the oxytocin receptor promoter (30) . MTA1 is a transcription repressor that associates with histone deacetylase complexes and is implicated in tumor progression (31) . ATRX is a chromatin remodeling factor that is also implicated in transcription regulation (32) .
EBNA2 also induced MAD1L1 (MAD1), which binds to kinetochores and has a critical role in regulating cdc20 and the spindle assembly checkpoint. MAD1 recruits MAD2 and activates formation of MAD2͞cdc20 complexes, which prevent cdc20 from activating the anaphase-promoting complex (33) . HTLV tax interacts with MAD1, targets MAD1 for degradation, and is implicated in genetic instability associated with the adult T cell leukemia (34) . In contrast, EBNA2 up-regulation of MAD1 may contribute to LCL chromosome stability by maintaining the spindle assembly checkpoint.
Although EBV-transformed LCLs are resistant to apoptosis as a consequence of LMP1-mediated NF-B activation and induction of A20, Bfl1, and Bcl2 (20, 35) , EBNA2 also contributes to cell survival through Nur77 (36) and up-regulation of AKAP1, GADD45␤, ATF5, and Jun D RNAs. AKAP1 anchors PKA to the mitochondria (37), resulting in phosphorylation and inactivation of BAD (38) . GADD45␤ protects cell from c-Jun N-terminal kinase-mediated apoptosis (39) . ATF5 is bZIP transcription factor, which inhibits IL-3 deprivation-induced apoptosis (40) . ATF5 is low in E2HTF LCLs grown in media with 4HT as compared with WT LCL and thus may contribute to the higher apoptotic rate of E2HTF LCLs in media with 4HT. Jun D is an AP-1 family transcription factor that protects cells from p53-dependent apoptosis (41) .
Other EBNA2-induced RNAs encode proteins involved in cell signaling. These include chemokines, receptors, coreceptors, and intracellular mediators such as CCL5 (Rantes), CD23A, CD21, CD22, CMKOR1 (G protein-coupled receptor), GRINA (glutamate receptor-associated protein), CD300A (leukocyte membrane antigen, Irp60), ATP1B1, PPP1R14B, RGS1, PTPN6 (SHP-1), PSPHL, SIPA1L1, IRAK1, and CD22. CD22 ligation triggers rapid CD22 tyrosine phosphorylation, c-Jun N-terminal kinase activation, and B cell proliferation (42) . CD22 also modulates B cell receptor signaling by recruiting SHP-1 protein tyrosine phosphatase (43) . CD300A is an Ig superfamily protein with an intracellular tail that has an immunoreceptor tyrosine-based inhibitory motif that can associate with SHP-1 (44, 45) . RDC1 (CMKOR1) is G protein-coupled receptor that binds to CXCL12 and is also an HIV coreceptor (46) . CCL5 and RGS1 GAP are also LMP1-induced and are likely to regulate B cell chemotaxis (20) . SIPA1L1 is a GAP homologue that is targeted for degradation by HPV E6 and is also induced in proliferating T lymphocytes after mitogen stimulation (47) . IRAK1 is critical for LMP1-mediated NF-B activation (48) .
EBNA2 also induced RNAs that encode proteins involved in adhesion and cytoskeleton remodeling, which usually accompanies B cell activation. These included TUBGCP2, EVL, CDK5R1, KTN1, and SNX11. TUBGCP2 attaches to the spindle pole body and is the template for microtubule polymerization (49) . CDK5R1 is an activator of cyclin-dependent kinase 5, which is usually expressed in neurons (50) . Activated cdk5 is implicated in microtubule organization and neuronal migration (51) . EVL is implicated in actin remodeling at adhesion focal points and can bind to SH3 domains and profilin (52) . KTN1 is an endoplasmic reticulum membrane protein that binds to kinesin to mediate intracellular organelle movement (53) . SNX11 is a sorting nexin family protein that can bind phospholipid and mediate endocytosis and protein trafficking among membranous compartments (54) .
LCLs infected with P3HR-1 EBV and a defective EBV that has multimers of a cassette that expresses a partially deleted EBNALP and a ER͞EBNA2 fusion protein has enabled the demonstration that c-myc transcriptional activation is direct and independent of new protein synthesis (5) . The system has also been used to show that NotchIC can partially complement EBNA2 and to investigate other aspects of the role of EBNA2 in LCL growth and RNA regulation (17, 55) . However, these cells underexpress LMP1 under permissive conditions, EBNALP function has not been investigated, and removal of estrogen causes growth arrest and apoptosis in 50% of the cells. Furthermore, ER͞EBNA2 fusion protein degrades more slowly than E2HTF and accumulates at a higher level. Moreover, estrogen activates ER hormone transcription effects, and 5 of 11 ER͞EBNA2 up-regulated genes were ER up-regulated (3). Six RNAs that were potentially EBNA2 upregulated included AML2͞RUNX1, GADD45␤, IL16, and Pleckstrin, which may have been NF-B up-regulated as a result of cyclohexamide and anisomysin addition along with estrogen (3, 20) .
Materials and Methods
Cell Culture. P3HR1 EBV-infected cells were used to generate recombinant EBVs (15) . IB4 is a lymphoblastoid cell line transformed by the B95-8 type I EBV. Five newly established LCLs were transformed by B95-8 virus (2) or WT recombinant EcoA cosmidrescued P3HR1 EBV (15) . E2HTF LCLs were established by transforming cord blood B lymphocytes with mutant recombinant EcoA cosmid-rescued P3HR1 EBV. P3HR1 and LCL cells were maintained in complete medium (24) .
Plasmids. EBNA2Flag from EBV strain W91 was subcloned from pSG5EBNA2Flag into pBI (Invitrogen). PCR-amplified 4HT-responsive modified ER hormone-binding domain was then inserted into the PvuII site between EBNA2-and Flag-encoding DNA, resulting in E2HTF. Continuity of ORFs was verified by DNA sequence as well as by Western blot with Flag (M2)-specific and EBNA2 (PE2)-specific monoclonal antibodies. A C-terminal NsiI fragment containing the E2HTF fusion was cloned in place of WT EBNA2 in the WT HindIII-CpoI fragment of the W91 EcoRIA cosmid. The HindIII-CpoI fragment carrying E2HTF was then cloned into the W91 EcoRIA cosmid. Western Blotting and Immune Fluorescence. Polyacrylamide gel electrophoresis, Western blotting, and immune fluorescence microscopy procedures were described in refs. 15 and 24. Blots were exposed to x-ray film or Kodak Image Station 400R by using Kodak MOLECULAR IMAGING software, version 4.0.
RNA and Northern Blots. Whole-cell RNA was prepared from WT EBV-transformed, IB4, or E2HTF-infected LCLs grown in complete medium supplemented with or without 4HT (4HTϩ or 4HTϪ) for 24 h by RNAzol (Tel-Test, Friendswood, TX). RNA (10 g) was separated in formaldehyde agarose gels and transferred to GeneScreen Plus nylon membrane (NEN). Membranes were hybridized with probe overnight at 42°C in NorthernMAX (Ambion, Austin, TX) hybridization buffer, washed with NorthernMAX wash buffer, exposed to a PhosphorImager screen, and analyzed with IMAGEQUANT software (Molecular Dynamics).
Microarray Analyses. cRNA was generated from total RNA and hybridized to Affymetrix human HU-133A oligonucleotide array chips. Expression data were analyzed by using Affymetrix MAS 5.0 software. Targeted expression was 500, and scaling factors were 0. 52-8.89 . Raw expression data were imported into GENESPRING 6.0 (Silicongenetics, Redwood City, CA). Values for all genes on each array were normalized to the median value. Each gene was then
